Insurance News & Info

LONDON (Reuters) – GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showe… View full post on Yahoo! Health News

NEW YORK (Reuters Health) – Older adults who have surgery for a particular type of lung cancer often have radiation therapy afterward. But a new study suggests that the radiation typically does nothing to extend their lives. The findings, which ap… View full post on Yahoo! Health News

SILVER SPRING, Maryland (Reuters) – An experimental inhaled lung treatment from Forest Laboratories Inc and Almirall SA won a U.S. panel's support on Thursday, a boost for the companies' chances of eventually gaining approval for a drug to… View full post on Yahoo! Health News

WASHINGTON (Reuters) – Drug reviewers said Forest Laboratories Inc and Almirall SA's inhaled lung treatment worked, but raised concerns about potential heart problems linked to drugs in the same class. Food and Drug Administration staff said o… View full post on Yahoo! Health News

MONDAY, Feb. 13 (HealthDay News) — For older people with a certain type and stage of lung cancer, administering radiation treatment after surgery may not extend survival, according to a new study. View full post on Yahoo! Health News

NEW YORK (Reuters Health) – A controversial radiation treatment for patients who've had lung cancer surgery may not help elderly people live longer, U.S. researchers have found. Postoperative radiotherapy, or PORT, is thought to cut the chance… View full post on Yahoo! Health News

Clinical trials in the United States and China have shown that a new gene-based test for patients with lung cancer beats standard methods in predicting survival, researchers reported Friday. View full post on Yahoo! Health News

THURSDAY, Jan. 26 (HealthDay News) — A new industry-funded study suggests that a molecular test can provide insight into whether patients are at high risk of a relapse after surgical treatment for a form of lung cancer. View full post on Yahoo! Health News

THURSDAY, Jan. 12 (HealthDay News) — Women who use antidepressants called selective serotonin-reuptake inhibitors such as Prozac and Celexa during pregnancy run a slight risk of having an infant with high blood pressure in the lungs, a new Swedis… View full post on Yahoo! Health News

WEDNESDAY, Jan. 11 (HealthDay News) — Lung cancer is the leading cancer killer in the world, and only about 15 percent of cases are diagnosed at an early stage, when it's most treatable. View full post on Yahoo! Health News